Shuttle Pharma receives Nasdaq delisting notice for low equity ($801K vs $2.5M)

Shuttle Pharmaceuticals Holdings, Inc.

Nasdaq notified Shuttle Pharma on Sept 10, 2024 of non-compliance with minimum stockholders' equity of $2.5M; reported equity $801,434.
Company has 45 days (until Oct 25, 2024) to submit a plan to regain compliance; Nasdaq may grant up to 180-day extension.
Non-compliance has no immediate effect on listing; if plan rejected or not met, securities could be delisted with appeal rights.
Company is evaluating actions to regain compliance but no assurance of success.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.